Dr. Md. Alimur Reza clinical trial pipeline

2 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 0 with minor changes only.

1. Stopped

   Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus…Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

   Trial status changed: Recruiting → Withdrawn

   Dr. Md. Alimur Reza·Phase 4· NCT06789432· Registry history of NCT06789432 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

2. Notable

   Tirzepatide · Obesity With or Without Type 2 Diabetes Mellitus…Tirzepatide · Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

   Primary completion pushed from Apr 2026 to Oct 2027

   Also in this update: Study completion pushed from Jul 2026 to Dec 2027

   Dr. Md. Alimur Reza·Not specified· NCT07099742· Registry history of NCT07099742 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.